<DOC>
	<DOCNO>NCT00900003</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue laboratory patient cancer may help doctor identify learn biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This research study study biomarkers patient pancreatic cancer .</brief_summary>
	<brief_title>Studying Biomarkers Patients With Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To determine whether cellular localization BRCA1 predict patient pancreatic cancer respond cytotoxic agent ( e.g. , fluorouracil gemcitabine hydrochloride ) radiotherapy . - To identify pre-treatment marker use correlate clinical outcome survival recurrence . - To determine method extract identify secrete cytokine growth factor biopsy tissue apply pancreatic cancer population . OUTLINE : Tissue sample biopsy perform pancreatectomy collect Vanderbilt Ingram Cancer Center Human Tissue Acquisition Core laboratory biomarker study . Proteins secrete cancer cell and/or cancer-associated cell study extract identify secrete cytokine growth factor biopsy tissue . The integrity DNA repair pathway pancreatic cancer analyze Rad51 phosphorylated DNA-PK focus formation . Markers correlate clinical outcome . Patients follow recurrence , relapse , death disease .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Inclusion criterion Any subject excess tissue collect time routine surgery pancreatic cancer eligible . All subject participate protocol follow recurrence , relapse death disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>stage I pancreatic cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>